A Genetic Model for the Inheritance of Pituitary Tumor Susceptibility in F344 Rats*
- 1 November 1981
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 109 (5) , 1708-1714
- https://doi.org/10.1210/endo-109-5-1708
Abstract
An 8-week period of continuous diethylstilbestrol (DES) treatment results in the development of pituitary tumors in 100% of male or female F344 rats. Similar treatment of Holtzman male or female rats results in a very low incidence of pituitary tumor development (2–6%). A series of crosses was performed between F344 and Holtzman rats to produce the F1 hybrid, the F2 generation, and the backcrosses of the Fi hybrid to either the F344 parent or the Holtzman parent. The incidence of DES-induced pituitary tumors was measured in these animals. The results indicate that pituitary tumor susceptibility does not result from the expression of genes that are simple dominant or recessive genes, since the tumor's incidence in the F1 hybrid is intermediate to that in the parental strains. However, the data are compatible with the involvement of a small number of genetic loci. We present a genetic model involving three independently segregating loci which agrees reasonably well with the experimental results. In the model, the Holtzman strain has normal alleles at these loci which prevent uncontrolled proliferation. The highly inbred F344 strain is homozygous mutant at these three loci and is unable to control DES-induced proliferation.Keywords
This publication has 5 references indexed in Scilit:
- A Comparison of Estrogen Effects on Uterine and Pituitary Growth and Prolactin Synthesis in F344 and Holtzman Rats*Endocrinology, 1981
- Oxidative metabolites of diethylstilbestrol in the fetal, neonatal and adult mouseBiochemical Pharmacology, 1978
- Xeroderma PigmentosumAnnals of Internal Medicine, 1974
- CHANGES IN HORMONE SENSITIVITY OF PITUITARY MAMMOTROPES DURING PROGRESSION FROM NORMAL TO AUTONOMOUS1961
- Studies on Ovarian and Pituitary Tumorigenesis12JNCI Journal of the National Cancer Institute, 1954